AdaptHealth Dividenden en inkoop

Dividend criteriumcontroles 0/6

AdaptHealth heeft geen dividenduitkeringen gedaan.

Belangrijke informatie

n/a

Dividendrendement

0.09%

Terugkoop Rendement

Totaal aandeelhoudersrendement	0.09%
Toekomstig dividendrendement	0%
Dividendgroei	n/a
Volgende betaaldatum dividend	n/a
Ex-dividenddatum	n/a
Dividend per aandeel	n/a
Uitbetalingsratio	n/a

Recente updates van dividend en inkoop

Geen updates

Recent updates

Adapt Operating System And Debt Reduction Will Transform Home Healthcare

May 15 AdaptHealth's focus on geographic expansion, managed care, and partnerships aims to boost market share and drive revenue growth in the home health industry.

We Think AdaptHealth's (NASDAQ:AHCO) Solid Earnings Are Understated

May 14

AdaptHealth Corp. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 09

Little Excitement Around AdaptHealth Corp.'s (NASDAQ:AHCO) Revenues

Apr 07

At US$10.02, Is It Time To Put AdaptHealth Corp. (NASDAQ:AHCO) On Your Watch List?

Mar 20

These 4 Measures Indicate That AdaptHealth (NASDAQ:AHCO) Is Using Debt Extensively

Feb 26

Be Wary Of AdaptHealth (NASDAQ:AHCO) And Its Returns On Capital

Jan 30

AdaptHealth Corp.'s (NASDAQ:AHCO) Revenues Are Not Doing Enough For Some Investors

Dec 10

We Think AdaptHealth (NASDAQ:AHCO) Is Taking Some Risk With Its Debt

Nov 13

Returns On Capital Signal Tricky Times Ahead For AdaptHealth (NASDAQ:AHCO)

Oct 22

AdaptHealth Corp.'s (NASDAQ:AHCO) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Sep 06

Is There An Opportunity With AdaptHealth Corp.'s (NASDAQ:AHCO) 37% Undervaluation?

Jul 14

Market Might Still Lack Some Conviction On AdaptHealth Corp. (NASDAQ:AHCO) Even After 50% Share Price Boost

Mar 07

AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business

Feb 16

Many Still Looking Away From AdaptHealth Corp. (NASDAQ:AHCO)

Jan 18

AdaptHealth (NASDAQ:AHCO) Use Of Debt Could Be Considered Risky

Nov 15

Returns On Capital At AdaptHealth (NASDAQ:AHCO) Paint A Concerning Picture

Oct 18

Is It Too Late To Consider Buying AdaptHealth Corp. (NASDAQ:AHCO)?

Sep 27

Here's What's Concerning About AdaptHealth's (NASDAQ:AHCO) Returns On Capital

Jul 19

Here's Why AdaptHealth (NASDAQ:AHCO) Is Weighed Down By Its Debt Load

Jul 04

Is Now The Time To Look At Buying AdaptHealth Corp. (NASDAQ:AHCO)?

Jun 16

AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business

Apr 10

Here's Why AdaptHealth (NASDAQ:AHCO) Is Weighed Down By Its Debt Load

Mar 22

Why AdaptHealth Corp. (NASDAQ:AHCO) Could Be Worth Watching

Feb 23

Investors Interested In AdaptHealth Corp.'s (NASDAQ:AHCO) Earnings

Jan 24

Stabiliteit en groei van betalingen

Dividenden ophalen

Stabiel dividend: Er zijn onvoldoende gegevens om te bepalen of het dividend per aandeel van AHCO in het verleden stabiel is geweest.

Groeiend dividend: Er zijn onvoldoende gegevens om te bepalen of de dividendbetalingen van AHCO zijn gestegen.

Dividendrendement versus markt

AdaptHealth Dividendrendement versus markt

Hoe verhoudt AHCO dividendrendement zich tot de markt?
Segment	Dividendrendement
Bedrijf (AHCO)	n/a
Markt onderkant 25% (US)	1.5%
Markt Top 25% (US)	4.7%
Gemiddelde industrie (Healthcare)	2.3%
Analist prognose (AHCO) (tot 3 jaar)	0%

Opmerkelijk dividend: Het dividendrendement van AHCO kan niet worden vergeleken met dat van de onderste 25% van de dividendbetalers, aangezien het bedrijf geen recente uitbetalingen heeft gerapporteerd.

Hoog dividend: Het dividendrendement van AHCO kan niet worden vergeleken met dat van de top 25% van de dividendbetalers, aangezien het bedrijf geen recente uitbetalingen heeft gerapporteerd.

Winstuitkering aan aandeelhouders

Verdiendekking: Er zijn onvoldoende gegevens om de payout ratio AHCO te berekenen en vast te stellen of de dividendbetalingen worden gedekt door de winst.

Contante uitbetaling aan aandeelhouders

Kasstroomdekking: De duurzaamheid van het dividend kan niet worden berekend, omdat AHCO geen uitbetalingen heeft gerapporteerd.

Ontdek bedrijven met een sterk dividend

Bedrijfsanalyse en status van financiële gegevens

Gegevens	Laatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse	2025/05/18 06:46
Aandelenkoers aan het einde van de dag	2025/05/16 00:00
Inkomsten	2025/03/31
Jaarlijkse inkomsten	2024/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

Pakket	Gegevens	Tijdframe	Voorbeeld Amerikaanse bron ^*
Financiële gegevens bedrijf	10 jaar	Resultatenrekening Kasstroomoverzicht Balans	SEC-formulier 10-K SEC-formulier 10-Q
Consensus schattingen analisten	+3 jaar	Financiële prognoses Koersdoelen analisten	Onderzoeksrapporten van analisten Blue Matrix
Marktprijzen	30 jaar	Aandelenprijzen Dividenden, splitsingen en acties	ICE Marktgegevens SEC-formulier S-1
Eigendom	10 jaar	Top aandeelhouders Handel met voorkennis	SEC-formulier 4 SEC-formulier 13D
Beheer	10 jaar	Leiderschapsteam Raad van bestuur	SEC-formulier 10-K SEC-formulier DEF 14A
Belangrijkste ontwikkelingen	10 jaar	Bedrijfsaankondigingen	SEC-formulier 8-K

^* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren, zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen voor het gebruik van onze rapporten en tutorials op Youtube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

AdaptHealth Corp. wordt gevolgd door 13 analisten. 9 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

Analist	Instelling
Eric Coldwell	Baird
Joanna Sylvia Gajuk	BofA Global Research
Kevin Fischbeck	BofA Global Research

AdaptHealth Dividenden en inkoop

Dividend criteriumcontroles 0/6

Belangrijke informatie

Recente updates van dividend en inkoop

Recent updates

Adapt Operating System And Debt Reduction Will Transform Home Healthcare

We Think AdaptHealth's (NASDAQ:AHCO) Solid Earnings Are Understated

AdaptHealth Corp. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

First quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind

AdaptHealth Corp. Updates Earnings Guidance for the Fiscal Year 2025

AdaptHealth Corp., Annual General Meeting, Jun 18, 2025

AdaptHealth Corp. to Report Q1, 2025 Results on May 06, 2025

Investor sentiment deteriorates as stock falls 17%

Little Excitement Around AdaptHealth Corp.'s (NASDAQ:AHCO) Revenues

At US$10.02, Is It Time To Put AdaptHealth Corp. (NASDAQ:AHCO) On Your Watch List?

Investor sentiment improves as stock rises 29%

New minor risk - Earnings quality

Price target increased by 8.9% to US$12.28

These 4 Measures Indicate That AdaptHealth (NASDAQ:AHCO) Is Using Debt Extensively

AdaptHealth Corp. Provides Financial Guidance for the Fiscal Year 2025

Full year 2024 earnings: EPS exceeds analyst expectations

AdaptHealth Corp. to Report Q4, 2024 Results on Feb 25, 2025

Be Wary Of AdaptHealth (NASDAQ:AHCO) And Its Returns On Capital

Chief Business Officer notifies of intention to sell stock

Chief Financial Officer recently sold US$327k worth of stock

AdaptHealth Corp.'s (NASDAQ:AHCO) Revenues Are Not Doing Enough For Some Investors

Adapthealth Corp. Appoints Russell Schuster as Chief Commercial Officer

Chief Business Officer notifies of intention to sell stock

We Think AdaptHealth (NASDAQ:AHCO) Is Taking Some Risk With Its Debt

Third quarter 2024 earnings: EPS misses analyst expectations

AdaptHealth Corp. Updates Financial Guidance for Fiscal Year 2024

Returns On Capital Signal Tricky Times Ahead For AdaptHealth (NASDAQ:AHCO)

AdaptHealth Corp. Appoints Diana Nole to Board of Directors

AdaptHealth Corp. to Report Q3, 2024 Results on Nov 05, 2024

Insufficient new directors

Insider recently sold US$281k worth of stock

AdaptHealth Corp.'s (NASDAQ:AHCO) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Adapthealth Corp. Announces Scott Barnhart as Chief Operating Officer, Effective September 23, 2024

AdaptHealth Corp. Announces Executive Changes

Second quarter 2024 earnings: EPS misses analyst expectations

AdaptHealth Corp. Updates Financial Guidance for the Fiscal Year 2024

AdaptHealth Corp. to Report Q2, 2024 Results on Aug 06, 2024

Is There An Opportunity With AdaptHealth Corp.'s (NASDAQ:AHCO) 37% Undervaluation?

AdaptHealth Corp. Announces Changes to Board of Directors and Management

Levi & Korsinsky LLP Encourages to File a Claim Against the Settlement Fund Before Deadline Against Adapthealth Corp

AdaptHealth Corp.'s (NASDAQ:AHCO) Low P/S No Reason For Excitement

Jerry W. Ray V. AdaptHealth Corp. Class Action Reaches Important Milestones

AdaptHealth (NASDAQ:AHCO) Is Reinvesting At Lower Rates Of Return

AdaptHealth Corp. Announces Goodwill Impairment for the First Quarter Ended March 31, 2024

First quarter 2024 earnings released: US$0.016 loss per share (vs US$0.11 profit in 1Q 2023)

AdaptHealth Corp. to Report Q1, 2024 Results on May 07, 2024

AdaptHealth Corp. Announces Richard Barasch Steps Down as Chairman of the Board, Effective June 30, 2024

AdaptHealth Corp., Annual General Meeting, Jun 20, 2024

Here's Why AdaptHealth (NASDAQ:AHCO) Has A Meaningful Debt Burden

Market Might Still Lack Some Conviction On AdaptHealth Corp. (NASDAQ:AHCO) Even After 50% Share Price Boost

Chief Technology Officer notifies of intention to sell stock

Insufficient new directors

AdaptHealth Corp. Provides Earnings Guidance for the Fiscal Year 2024

Price target increased by 13% to US$11.70

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business

AdaptHealth Corp. to Report Q4, 2023 Results on Feb 27, 2024

Consensus EPS estimates fall by 34%

Many Still Looking Away From AdaptHealth Corp. (NASDAQ:AHCO)

Price target decreased by 8.7% to US$10.50

Rosen Law Firm Encourages AdaptHealth Corp. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action

AdaptHealth (NASDAQ:AHCO) Use Of Debt Could Be Considered Risky

New minor risk - Share price stability

Adapthealth Corp. Updates Revenue Guidance for the Year 2023

Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of Securities Class Action Lawsuit Against AdaptHealth Corp

AdaptHealth Corp. to Report Q3, 2023 Results on Nov 07, 2023

Returns On Capital At AdaptHealth (NASDAQ:AHCO) Paint A Concerning Picture

Investor sentiment deteriorates as stock falls 16%

Is It Too Late To Consider Buying AdaptHealth Corp. (NASDAQ:AHCO)?

Adapthealth Corp. Announces CEO Changes

Investor sentiment deteriorates as stock falls 17%

Chief Technology Officer notifies of intention to sell stock

AdaptHealth Corp. Provides Revenue Guidance for the Fiscal Year 2023

Price target increased by 8.3% to US$17.03

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind